HOME >> MEDICINE >> NEWS
Genetics likely to be a major factor in osteoarthritis of the hip

Assessment of a genetic contribution to osteoarthritis of the hip: sibling study

Click below to download PDF document
You will require Acrobat Reader to view file
Click here for PDF document

Siblings have a five fold increased risk of developing osteoarthritis of the hip compared with unrelated individuals, which suggests a strong genetic influence on susceptibility to the disease, according to research from Nottingham in this week's BMJ.

Peter Lanyon and colleagues from Nottingham University contrasted 392 patients with osteoarthritis and 604 of their siblings against a control group of 1,718 other patients.

Other research has already demonstrated a family link for osteoarthritis of the hand and knee but this large-scale study now confirms earlier research suggesting a link in osteoarthritis of the hip. The Nottingham research shows that the risk to siblings is even greater than previously thought, at around three to eightfold the rate of prevalence in unrelated people.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-20-7383-6529
BMJ-British Medical Journal
9-Nov-2000


Page: 1

Related medicine news :

1. Genetics important in age-related macular degeneration
2. Genetics testing saves health care dollars
3. Genetics of familial atrial fibrillation revealed, Science researchers report
4. Genetics in clinical practice: a revolutionary approach
5. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
6. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
7. Blacks less likely to get expensive, newer heart treatments
8. Women less likely to get quality heart attack care
9. English-speaking Hispanic youth more likely to have sex early
10. Men more likely to get screened for prostate cancer than colon cancer, U-M study finds
11. A safer route to school makes children more likely to walk and bike, study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick Taché ... Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a ... & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology:
Cached News: